PetIQ, Inc.

NasdaqGS:PETQ Stock Report

Market Cap: US$926.6m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

PetIQ Valuation

Is PETQ undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of PETQ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate PETQ's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate PETQ's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for PETQ?

Key metric: As PETQ is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for PETQ. This is calculated by dividing PETQ's market cap by their current earnings.
What is PETQ's PE Ratio?
PE Ratio69.7x
EarningsUS$13.19m
Market CapUS$926.64m

Price to Earnings Ratio vs Peers

How does PETQ's PE Ratio compare to its peers?

The above table shows the PE ratio for PETQ vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average24.7x
PDCO Patterson Companies
17.6x13.0%US$2.7b
HSIC Henry Schein
28.5x26.7%US$8.9b
CAH Cardinal Health
23x7.4%US$29.0b
COR Cencora
30x14.8%US$44.2b
PETQ PetIQ
69.7x60.0%US$926.6m

Price-To-Earnings vs Peers: PETQ is expensive based on its Price-To-Earnings Ratio (69.7x) compared to the peer average (23.4x).

Price to Earnings Ratio vs Industry

How does PETQ's PE Ratio compare vs other companies in the US Healthcare Industry?

3 CompaniesPrice / EarningsEstimated GrowthMarket Cap
THC Tenet Healthcare
3.9x-30.6%US$11.95b
NEUE NeueHealth
2.2xn/aUS$60.66m
IDXG Interpace Biosciences
2.1xn/aUS$11.18m
No more companies available in this PE range
PETQ 69.7xIndustry Avg. 22.5xNo. of Companies10PE01632486480+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: PETQ is expensive based on its Price-To-Earnings Ratio (69.7x) compared to the US Healthcare industry average (24.5x).

Price to Earnings Ratio vs Fair Ratio

What is PETQ's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

PETQ PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio69.7x
Fair PE Ratio67x

Price-To-Earnings vs Fair Ratio: PETQ is expensive based on its Price-To-Earnings Ratio (69.7x) compared to the estimated Fair Price-To-Earnings Ratio (67x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst PETQ forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Currentn/a
US$30.67
0%
1.5%US$31.00US$30.00n/a3
Jan ’26n/a
US$30.67
0%
1.5%US$31.00US$30.00n/a3
Dec ’25n/a
US$30.67
0%
1.5%US$31.00US$30.00n/a3
Nov ’25n/a
US$30.67
0%
1.5%US$31.00US$30.00n/a3
Oct ’25US$30.77
US$30.67
-0.3%
1.5%US$31.00US$30.00n/a3
Sep ’25US$30.55
US$30.67
+0.4%
1.5%US$31.00US$30.00n/a3
Aug ’25US$21.44
US$29.00
+35.3%
3.4%US$30.00US$28.00n/a4
Jul ’25US$22.87
US$29.00
+26.8%
3.4%US$30.00US$28.00n/a4
Jun ’25US$20.76
US$29.00
+39.7%
3.4%US$30.00US$28.00n/a4
May ’25US$16.87
US$29.00
+71.9%
3.4%US$30.00US$28.00n/a4
Apr ’25US$18.49
US$29.00
+56.8%
3.4%US$30.00US$28.00n/a4
Mar ’25US$17.37
US$28.00
+61.2%
8.7%US$30.00US$24.00n/a4
Feb ’25US$18.29
US$27.50
+50.4%
11.9%US$30.00US$22.00n/a4
Jan ’25US$19.75
US$27.50
+39.2%
11.9%US$30.00US$22.00n/a4
Dec ’24US$18.14
US$29.33
+61.7%
3.2%US$30.00US$28.00n/a3
Nov ’24US$18.69
US$29.33
+56.9%
3.2%US$30.00US$28.00n/a3
Oct ’24US$19.70
US$27.67
+40.4%
7.4%US$30.00US$25.00US$30.773
Sep ’24US$19.11
US$27.50
+43.9%
9.1%US$30.00US$25.00US$30.552
Aug ’24US$16.72
US$25.00
+49.5%
20.0%US$30.00US$20.00US$21.442
Jul ’24US$15.17
US$25.00
+64.8%
20.0%US$30.00US$20.00US$22.872
Jun ’24US$13.18
US$23.67
+79.6%
19.0%US$30.00US$20.00US$20.763
May ’24US$11.82
US$23.67
+100.2%
19.0%US$30.00US$20.00US$16.873
Apr ’24US$11.44
US$21.75
+90.1%
23.5%US$30.00US$16.00US$18.494
Mar ’24US$10.18
US$21.75
+113.7%
23.5%US$30.00US$16.00US$17.374
Feb ’24US$12.20
US$24.25
+98.8%
24.8%US$30.00US$16.00US$18.294
Jan ’24US$9.22
US$24.25
+163.0%
24.8%US$30.00US$16.00US$19.754

Analyst Forecast: Target price is lower than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/10/24 20:18
End of Day Share Price 2024/10/24 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

PetIQ, Inc. is covered by 8 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
John LawrenceBenchmark Company
David WestenbergCL King & Associates, Inc.
David WestenbergGuggenheim Securities, LLC